Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer
CONCLUSION: Patients with PU recurrences following intravesical BCG have a high-risk disease phenotype with a significant risk of recurrence. Conservative management may be appropriate for well-selected patients who do not desire a cystoprostatectomy.PMID:38688797 | DOI:10.1016/j.urolonc.2024.04.017
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Justin W Ingram Rainjade Chung Caroline Laplaca James M McKiernan Andrew T Lenis Christopher B Anderson Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Study | Urology & Nephrology